Literature DB >> 15331511

Oligonucleotide microarray-based mutation detection of the K-ras gene in colorectal cancers with use of competitive DNA hybridization.

Jae-Hyun Park1, Il-Jin Kim, Hio Chung Kang, Yong Shin, Hye-Won Park, Sang-Geun Jang, Ja-Lok Ku, Seok-Byung Lim, Seung-Yong Jeong, Jae-Gahb Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15331511     DOI： 10.1373/clinchem.2004.034017

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  8 in total

1.  Development and applications of a BRAF oligonucleotide microarray.

Authors:  Il-Jin Kim; Hio Chung Kang; Sang Geun Jang; Sun-A Ahn; Hyun-Ju Yoon; Jae-Gahb Park
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

2.  Development of a gLCR-based KRAS mutation detection approach and its comparison with other screening methods.

Authors:  Stefan Jenner; Dieter Techel
Journal:  Tumour Biol       Date:  2015-03-27

3.  Microarray applications in cancer research.

Authors:  Il-Jin Kim; Hio Chung Kang; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2004-08-31       Impact factor: 4.679

4.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

5.  Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.

Authors:  I-J Kim; J-L Ku; H C Kang; J-H Park; K-A Yoon; Y Shin; H-W Park; S G Jang; S-K Lim; S Y Han; Y-K Shin; M R Lee; S-Y Jeong; H-R Shin; J S Lee; W-H Kim; J-G Park
Journal:  Hum Genet       Date:  2004-09-24       Impact factor: 4.132

Review 6.  Clinical relevance of KRAS in human cancers.

Authors:  Sylwia Jancík; Jirí Drábek; Danuta Radzioch; Marián Hajdúch
Journal:  J Biomed Biotechnol       Date:  2010-06-07

7.  Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations.

Authors:  Chih-Chieh Chen; Tze-Kiong Er; Yen-Yi Liu; Jenn-Kang Hwang; Maria Jesus Barrio; Maximiliano Rodrigo; Enrique Garcia-Toro; Marta Herreros-Villanueva
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 8.  Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy.

Authors:  David Z Chang; Vikas Kumar; Ying Ma; Kuiyuan Li; Scott Kopetz
Journal:  J Hematol Oncol       Date:  2009-04-22       Impact factor: 17.388
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.